Methodological quality assessment
| Methodological quality item | Alhassan et al 201217 | Bellows et al 201318 | Bonvin et al 201319 | Hardy et al 201023 | Jones et al 201120 | Robinson and Goodway 200922 | Tsapakidou et al 201421 |
|---|---|---|---|---|---|---|---|
| Key baseline characteristics reported separately for each group | + | − | + | − | − | − | − |
| Randomisation procedure clearly described | − | − | + | − | + | − | −− |
| Valid measure of FMS | + | + | + | + | + | + | + |
| Dropout ≤20% for <6 months follow-up or ≤30% for ≥6 months follow-up | + | − | + | + | + | + | + |
| Assessor blinding | − | − | + | + | + | − | − |
| Motor development assessed a min of 6 months after pretest | + | − | + | + | − | − | − |
| Intention-to-treat analysis | − | − | + | + | + | − | + |
| Potential confounders accounted for in analysis | + | + | + | + | + | − | − |
| Summary results presented+treatment effect+precision estimates | + | − | + | + | + | − | − |
| Power calculation reported | − | − | + | + | − | − | − |
| Total score | 6 | 2 | 10 | 8 | 7 | 2 | 3 |